News from milliporesigma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 08, 2020, 08:30 ET MilliporeSigma Celebrates Topping-Out Ceremony for New Membrane Production Plant

MilliporeSigma today celebrated the topping-out ceremony for its new membrane production plant in Darmstadt, Germany. With the new facility, the...


Oct 06, 2020, 13:00 ET MilliporeSigma Inaugurates New, Upgraded Onsite Industrial Water Treatment Plant

MilliporeSigma today inaugurated a new $14.4 million industrial water treatment plant at its Jaffrey, New Hampshire, location. The upgraded system...


Sep 09, 2020, 09:00 ET MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion

MilliporeSigma today announced a $65 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison,...


May 27, 2020, 09:15 ET MilliporeSigma and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19

MilliporeSigma and Baylor College of Medicine today announced an extension of their ongoing collaboration to advance a manufacturing platform to...


May 11, 2020, 09:00 ET MilliporeSigma Granted U.S. Patents for Foundational CRISPR-Cas9 Technology

MilliporeSigma, a leader in genome editing, today announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the...


Apr 14, 2020, 08:00 ET MilliporeSigma Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing

MilliporeSigma and The Jenner Institute today announced that The Jenner Institute has laid the foundation for large-scale production of its Covid-19...


Apr 07, 2020, 08:00 ET MilliporeSigma Awarded Second U.S. Patent for CRISPR Gene-Editing Technology

MilliporeSigma, a leader in genome editing, today announced that the United States Patent and Trademark Office has granted the company's patent for...


Mar 03, 2020, 14:00 ET MilliporeSigma's New LANEXO™ System to Improve Scientists' Productivity in the Lab

MilliporeSigma today launched its LANEXO™ Lab Inventory, Safety and Compliance Management System, a new digital laboratory informatics solution...


Dec 19, 2019, 08:00 ET MilliporeSigma Licenses Foundational CRISPR Integration Technology to Promega

MilliporeSigma, a leader in genome editing, today announced that it has signed a license agreement providing Promega Corp., a global life science...


Nov 26, 2019, 08:00 ET Japan and Singapore Grant CRISPR Patents to MilliporeSigma

MilliporeSigma today announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed its patent...


Nov 12, 2019, 08:00 ET MilliporeSigma Licenses CRISPR Gene-Editing Technology to Evotec

MilliporeSigma today announced that it has signed a license agreement providing Evotec SE access to MilliporeSigma's foundational CRISPR intellectual ...


Aug 19, 2019, 08:00 ET MilliporeSigma Granted 20 CRISPR Patents Total Worldwide

MilliporeSigma, a leader in genome editing, today announced that the European, Israeli, South Korean and U.K. intellectual property offices have...


Jul 18, 2019, 08:00 ET MilliporeSigma and Broad Institute Announce CRISPR License Framework to Encourage Innovation

MilliporeSigma and the Broad Institute of MIT and Harvard today announced an agreement to offer non-exclusive licenses to CRISPR intellectual...


Jun 20, 2019, 13:30 ET Massachusetts-based Business Sectors of Merck KGaA, Darmstadt, Germany Named 'Best Places to Work' by Boston Business Journal

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that its Massachusetts-based business sectors,...


May 20, 2019, 08:00 ET MilliporeSigma Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing

MilliporeSigma today announced its participation in a collaboration with the Vaccine Formulation Institute and the European Vaccine Initiative. The...


Mar 20, 2019, 05:30 ET MilliporeSigma Opens First M Lab™ Collaboration Center in Europe

MilliporeSigma today officially opened its new M Lab™ Collaboration Center in Molsheim, France. The center is MilliporeSigma's first in Europe and...


Mar 19, 2019, 06:30 ET MilliporeSigma to Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China

MilliporeSigma today announced the signing of a non-binding Memorandum of Understanding with GenScript for a strategic alliance focusing on plasmid...


Mar 04, 2019, 08:00 ET MilliporeSigma Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

MilliporeSigma, a leader in genome editing, today announced that the Canadian Patent Office has allowed MilliporeSigma's patent application directed...


Feb 19, 2019, 08:00 ET MilliporeSigma Receives First U.S. Patent for Improved CRISPR Genome-Editing Method

MilliporeSigma, a leader in genome editing, today announced that the United States Patent and Trademark Office has issued a formal notice allowing...


Dec 10, 2018, 11:30 ET MilliporeSigma and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models

MilliporeSigma, a leader in genome editing, today announced a strategic alliance in the CRISPR/Cas9 rodent model market with France-based...


Nov 27, 2018, 08:00 ET MilliporeSigma Wins Two R&D 100 Awards for Innovation in 2018

MilliporeSigma today announced that it has won two R&D 100 Awards. The 56th annual R&D 100 Awards program, honoring the 100 most innovative and...


Nov 05, 2018, 10:00 ET MilliporeSigma Launches BioContinuum™ Platform for Next-Generation Process Improvements

MilliporeSigma today launched its new BioContinuum™ Platform to advance biotherapeutic drug manufacturing through improved efficiency, simplified...


Oct 04, 2018, 08:00 ET MilliporeSigma Opens M Lab™ Collaboration Center in São Paulo, Brazil

MilliporeSigma today officially opened a state-of-the-art M Lab™ Collaboration Center in Brazil, serving the Latin America region. The center will...


Aug 15, 2018, 08:00 ET MilliporeSigma Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology

MilliporeSigma today announced that the Australian Patent Office has allowed the company's patent application for the use of paired CRISPR nickases....